Vaxxinity Investor Relations Material
Latest events
Q4 2023
27 Mar, 2024
Corporate Presentation
12 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vaxxinity Inc
Access all reports
Vaxxinity Inc. is a biotechnology company focused on developing immunotherapies for chronic diseases and infectious conditions. The company specializes in vaccine-based treatments designed to harness the immune system for conditions such as neurodegenerative disorders, cardiovascular diseases, and viral infections. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
VAXX
Country
🇺🇸 United States